title: [Medical treatment of tuberculosis - update 2011].
abstract: Tuberculosis is the second most common cause of death from an infectious disease after HIV/AIDS and the leading cause of death from an infectious disease in HIV-co-infected patients. Currently, drug susceptible TB is treated with a four drug regimen given over a period of two months followed by two drugs for four months. Drug resistant tuberculosis requires more complex and longer treatment with alternative substances. New antituberculosis drugs are currently being developed and investigated and are urgently needed to treat drug susceptible and drug resistant TB.
authors: Division of Pulmonology, Department of Medicine, Stellenbosch Universität, Kapstadt, Südafrika.
authors: Florian
authors: F
authors: von Groote-Bidlingmaier
authors: Andreas H
authors: AH
authors: Diacon
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000401:mortality; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D054908:Extensively Drug-Resistant Tuberculosis / Q000188:drug therapy / Q000401:mortality; D006801:Humans; D038622:Internationality; D008826:Microbial Sensitivity Tests; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy / Q000401:mortality; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000401:mortality
chemical_list: D000995:Antitubercular Agents